These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1291088)

  • 1. Dofetilide, a new class III antiarrhythmic agent, reduces pacing induced heterogeneity of repolarisation in vivo.
    Gwilt M; King RC; Milne AA; Solca AM
    Cardiovasc Res; 1992 Nov; 26(11):1102-8. PubMed ID: 1291088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
    Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
    Gwilt M; Blackburn KJ; Burges RA; Higgins AJ; Milne AA; Solca AM
    Eur J Pharmacol; 1992 May; 215(2-3):137-44. PubMed ID: 1396982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart.
    Pickoff AS; Stolfi A
    Pacing Clin Electrophysiol; 2001 May; 24(5):816-23. PubMed ID: 11388101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
    Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N
    Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dofetilide versus quinidine for atrial flutter: viva la difference!?
    Olshansky B
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):828-32. PubMed ID: 8884511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1999 Sep; 81(1):79-85. PubMed ID: 10580374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of the QT interval by dofetilide modulates rate-dependent effects of mexiletine on intraventricular conduction.
    Todt H; Zojer N; Raberger G; Schütz W
    Eur J Pharmacol; 1994 Nov; 265(1-2):43-52. PubMed ID: 7883028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dofetilide, a novel class III antiarrhythmic agent.
    Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation.
    Li D; Bénardeau A; Nattel S
    Circulation; 2000 Jul; 102(1):104-12. PubMed ID: 10880422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.
    Lande G; Maison-Blanche P; Fayn J; Ghadanfar M; Coumel P; Funck-Brentano C
    Clin Pharmacol Ther; 1998 Sep; 64(3):312-21. PubMed ID: 9757155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
    Feld GK; Cha Y
    J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug effects on premature beats are partly determined by prior cardiac activation frequency in perfused guinea-pig heart.
    Osadchii OE
    Exp Physiol; 2020 May; 105(5):819-830. PubMed ID: 32175633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of dofetilide on ventricular repolarization during steady state and during restitution in vivo.
    Todt H; Zojer N; Schütz W
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):1010-3. PubMed ID: 7898064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of the class III antiarrhythmic agent dofetilide (UK-68,798) in humans.
    Tham TC; MacLennan BA; Burke MT; Harron DW
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):507-12. PubMed ID: 7681516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of delayed rectifier K+ current by dofetilide and E-4031 differentially affects electrical cardiac responses to vagus stimulation in anesthetized dogs.
    Imamura H; Furukawa Y; Kasama M; Hoyano Y; Yonezawa T; Chiba S
    Jpn J Pharmacol; 1998 Jan; 76(1):31-7. PubMed ID: 9517402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.
    Chen J; Komori S; Li B; Tamura K; Hashimoto K
    Br J Pharmacol; 1996 Nov; 119(5):937-42. PubMed ID: 8922743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs.
    Mortensen E; Yang T; Refsum H
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):216-21. PubMed ID: 1376791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.